Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F
22/10, Oxford University Press, Oxford, Brooks, A.L., D.G
Cycle Duration and Monitoring Typical cycle: 1224 weeks Monitoring: baseline and 1012 week IGF-1 measurement is the most common biomarker Washout: 48 weeks between cycles is standard practitioner practice Contraindications Active malignancy GH/IGF-1 axis elevation is a theoretical oncogenic concern Diabetes mellitus GH elevates insulin resistance
5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that methylates nicotinamide using SAM as a methyl donor
US$ 23.52
US$ 28.50
US$ 22.76
US$ 24.94
